Metalmark Capital Analysis
What is Metalmark Capital?
Growth equity in middle-market energy, industrials, healthcare
Location
New York, New York, United States
Employees
11-50
Founded
2004
Product Features & Capabilities
- Growth equity investments in energy
- Growth equity investments in industrials
- Growth equity investments in infrastructure
- Growth equity investments in agribusiness
- Growth equity investments in healthcare
Investment Focus
Metalmark Capital primarily focuses on growth equity investments in founder-owned businesses within the middle market. The firm aims to build long-term value through active and collaborative partnerships with business owners. Its investment strategy includes sectors such as healthcare, industrials, and agribusiness. Metalmark Capital typically engages in investments that allow for geographic, customer, and product expansions, indicating a preference for transformational opportunities.
Assets Under Management
$8.5 billion
Investment Geography
Metalmark Capital primarily invests in privately held companies with a significant strategic footprint and growth objective in the North American market.
Key Portfolio Companies
- Aegis Sciences Corporation - Provides drug monitoring and toxicology services to pain management physicians, sports leagues, academic institutions, and government agencies in the U.S.
- Aqua Capital Management LP - Owns and manages a portfolio of water right assets throughout the western United States.
- Camin Cargo Control Inc. - A leading third-party service provider to the downstream energy industry, offering inspection, laboratory testing, and additive treatment services.
- Cross Country Healthcare - Provides qualified nursing staff on a contract basis to acute care hospitals and has grown to be one of the largest healthcare staffing services in the U.S.
- Innovetive Petcare - Acquires and operates specialty and general practice veterinary hospitals and clinics for companion animals in the southern and southeastern U.S.
- Premier Research - A middle-market contract research organization that provides clinical development and support services to pharmaceutical, biotech, and medical device customers.
- Sebela Pharmaceuticals - Focuses on the commercialization and development of marketed pharmaceuticals in the U.S. across gastroenterology, dermatology, and women’s health.
- Renewable Biofuels - Owns and operates the largest biodiesel production facility in North America.
- Vanguard Health Systems - Formed to acquire and convert primarily not-for-profit healthcare systems into investor-owned entities.
- WorldStrides - A leading provider of educational travel programs, offering experiential learning opportunities to students and teachers globally.
Notable Exits
- Jasper Therapeutics - A biotechnology company focused on developing novel antibody therapies for stem cell transplants. The specific exit method is not detailed.
- Orgenesis - A company that focuses on therapeutic treatments for diabetes. Metalmark Capital's exit involved the acquisition of Octomera by Orgenesis on January 31, 2024. Metalmark sold its stake in Octomera, which was a cell processing services subsidiary, and will receive a 5% royalty on net revenue for three years.
- Premier Research - A biotech startup that assists biopharmaceutical and medical device companies in bringing their developments to market. The exit method is not specified.
- Airborne Systems - A designer and manufacturer of parachutes, sold to TransDigm Group for approximately $250 million in cash.
- Camin Cargo Control - Acquired on November 8, 2023, by Macquarie Capital Principal Finance, with undisclosed valuation details.
- Nexant - Acquired on May 12, 2021, by Resource Innovations, with valuation details also undisclosed.
Recent Fundraising
$5 million
Management Team
- Howard I. Hoffen - Chairman & CEO
- Kenneth F. Clifford - Partner & Chief Financial Officer
- Michael C. Hoffman - Partner
- Gregory D. Myers - Partner
- John Eppel - Managing Director
- Peter Singh - Managing Director
- Vanessa L. Adler - Principal and Director of Investor Relations
- David J. Boudo - Principal
- M. Glen Itwaru - Principal
- Josh Hyman - Vice President
- Nitin Saxena - Vice President
- Jared Fogel - Vice President
- Justin Bartenbach - Associate
Other Considerations
Manages $3.3 billion in aggregate capital commitments; Founded in 2004; Based in New York, US; Active in North American market; Invests in founder-owned businesses
